Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Risk factors and the impact of comorbidities in patients developing urethral stricture after transurethral resection of the prostate.

World journal of urology·2026
Same author

Impact of metabolic syndrome and its components on the tumor aggressiveness of renal cell carcinoma.

Medicine·2026
Same author

Predictive value of the S.T.O.N.E. score for stone-free rate in impacted ureteral stones.

Urolithiasis·2025
Same author

Predictive Value of MAP and E-PASS Scores for Postoperative Complications following Laparoscopic Total and Partial Adrenalectomy.

Urologia internationalis·2025
Same author

Reply to Editorial Comment on "Stone Impaction Risk Score: Settling the Debate or Sparking a New One?"

Urology·2025
Same author

Dorsal Penile Curvature in Children: A Review.

Urology journal·2025

Related Experiment Video

Updated: Apr 4, 2026

A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound
06:08

A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound

Published on: March 21, 2025

2.0K

How should prostate specific antigen be interpreted?

Ali Atan1, Özer Güzel1

  • 1Department of Urology, Ankara Numune Training and Research Hospital, Ankara, Turkey.

Turkish Journal of Urology
|September 2, 2015
PubMed
Summary
This summary is machine-generated.

Serum prostate-specific antigen (PSA) testing is crucial in urology. Current recommendations suggest lower PSA limits for screening, especially for younger men, emphasizing informed patient consent.

Keywords:
MalePSAscreening

More Related Videos

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
13:19

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Published on: November 2, 2013

17.3K
Detection and Isolation of Cancer in Prostate Biopsies Using Stimulated Raman Histology and Artificial Intelligence
08:05

Detection and Isolation of Cancer in Prostate Biopsies Using Stimulated Raman Histology and Artificial Intelligence

Published on: June 10, 2025

1.4K

Related Experiment Videos

Last Updated: Apr 4, 2026

A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound
06:08

A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound

Published on: March 21, 2025

2.0K
Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
13:19

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Published on: November 2, 2013

17.3K
Detection and Isolation of Cancer in Prostate Biopsies Using Stimulated Raman Histology and Artificial Intelligence
08:05

Detection and Isolation of Cancer in Prostate Biopsies Using Stimulated Raman Histology and Artificial Intelligence

Published on: June 10, 2025

1.4K

Area of Science:

  • Urology
  • Oncology
  • Biochemistry

Background:

  • Serum prostate-specific antigen (PSA) measurement is a cornerstone of urological practice.
  • Initial upper PSA limit was 4 ng/mL; current recommendations advocate for lower limits (2.5-3 ng/mL) for specific age groups.
  • The utility of PSA in prostate cancer screening remains debated, yet it is vital for high-risk patient evaluation.

Purpose of the Study:

  • To review the current clinical applications and recommendations for serum PSA testing.
  • To highlight the evolving understanding of PSA thresholds in prostate cancer detection.
  • To emphasize the importance of patient counseling regarding PSA testing.

Main Methods:

  • Review of clinical guidelines and literature on PSA testing.
  • Analysis of historical and current PSA level recommendations.
  • Discussion of PSA's role in prostate cancer screening and monitoring.

Main Results:

  • PSA testing is widely utilized in urology.
  • Recommended upper PSA limits have decreased, particularly for younger demographics.
  • PSA remains a key tool for monitoring at-risk populations for prostate cancer.

Conclusions:

  • PSA testing should be conducted at appropriate intervals for selected individuals.
  • Informed patient consent detailing the test's implications is essential.
  • Age-specific PSA thresholds and careful patient selection optimize test utility.